![Fredrik Järrsten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fredrik Järrsten
Director of Finance/CFO at
OREXO AB
Net worth: 92 413 $ as of 2026-05-30
Profile
Fredrik Järrsten is currently Chief Executive Officer & Director at Mr. Järrsten Konsult AB, Chairman at Terroir Suisse AB, Director at Absorbest AB, and Chief Financial Officer & Executive Vice President at Orexo AB since 2022.
Former roles include Chief Financial Officer and Deputy CEO at Karolinska Development AB from 2019 to 2021, Chief Financial & Deputy Chief Executive Officer at Karolinska Development AB (Private Equity) from 2019 to 2021, Chief Financial Officer at Vivesto AB from 2021 to 2022, CFO & Head-Business Development at Bactiguard Holding AB from 2014 to 2017, Director-Business Development at Aleris Holding AB from 2006 to 2014, Investment Manager at Lazard AB from 1996 to 1999, and Investment Manager at Litorina Capital Advisors AB. Education includes undergraduate studies at Stockholm School of Economics and Stephen M.
Ross School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OREXO AB 0.12% | 2025-12-30 | 41,623 ( 0.12% ) | 92 413 $ | 2026-05-30 |
Fredrik Järrsten active positions
| Companies | Position | Start |
|---|---|---|
| OREXO AB | Director of Finance/CFO | 2022-08-31 |
Terroir Suisse AB | Chairman | - |
Fredrik Järrsten Konsult AB | Chief Executive Officer | - |
Absorbest AB
 Absorbest AB Medical SpecialtiesHealth Technology Develops and manufactures advanced wound care and fluid management products for healthcare market | Director/Board Member | - |
Former positions of Fredrik Järrsten
| Companies | Position | End |
|---|---|---|
| VIVESTO AB | Director of Finance/CFO | 2022-06-30 |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Chief Executive Officer | 2021-03-30 |
| KDVENTURES AB | Director of Finance/CFO | 2021-02-28 |
| BACTIGUARD HOLDING AB | Director of Finance/CFO | 2017-09-14 |
Aleris Holding AB
 Aleris Holding AB Miscellaneous Commercial ServicesCommercial Services Owns and manages real & movable properties | Corporate Officer/Principal | 2014-05-31 |
Training of Fredrik Järrsten
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
23
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Litorina Capital Advisors AB
 Litorina Capital Advisors AB Investment ManagersFinance Litorina Capital invests in companies located in the Nordic region, primarily in Sweden with an enterprise value of between SEK 200 - 1000 million. The firm targets companies operating in the fields of consumer and business services. It provides financing for buyout transactions and seeks majority stake position. | Finance |
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Stockholm School of Economics
 Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Finance |
Vivesto AB
 Vivesto AB Pharmaceuticals: GenericHealth Technology Develops cancer drugs based on nanotechnology for human and veterinary use | Health Technology |
Lazard AB
 Lazard AB Investment ManagersFinance Provides investment advisory services | Finance |
Aleris Holding AB
Aleris Holding AB Miscellaneous Commercial ServicesCommercial Services Owns and manages real & movable properties | Commercial Services |
Stephen M. Ross School of Business
 Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karolinska Development AB
 Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Bactiguard Holding AB
 Bactiguard Holding AB Medical SpecialtiesHealth Technology Provides solutions for reducing healthcare-related infections | Health Technology |
Terroir Suisse AB | |
Fredrik Järrsten Konsult AB | |
Absorbest AB
Absorbest AB Medical SpecialtiesHealth Technology Develops and manufactures advanced wound care and fluid management products for healthcare market | Health Technology |
- Stock Market
- Insiders
- Fredrik Järrsten
